Following Shaare Zedek Medical Center (SZMC) IRB approval (SZMC-0001-16) and given that the study was based on patient records, informed consent was waived. A retrospective case-control study was conducted on women who underwent caesarean delivery (CD) between August 2005 and December 2015 in SZMC, Jerusalem, Israel.
Clinical setting
The SZMC is a 1000-bed university-affiliated acute care hospital with a Division of Obstetrics that includes a high risk pregnancy unit, 2 delivery suites with 16 delivery rooms attached dedicated two obstetric operating rooms and 4 maternity wards. There were approximately 14,000 annual delivery admissions during the study period.
Inclusion/exclusion criteria: The study group consisted of women admitted with PPROM at gestational weeks (GW) 24–36 undergoing CD within 7 days of admission and prior to GW37. Previous studies have demonstrated a 10% risk of IAI in this population [10]. Control consisted of women undergoing CD at GW37-40, with no rupture of membranes or trial of labour. Intraamniotic infection risk in this population is considered approximately 1.7% [12], though little quality data exists. Vaginal delivery, rupture of membranes prior to GW24, rupture of membranes or trial of labour after GW37, delivery within 24 hours of PPROM and delivery > 7 days after admission were exclusion criteria. Case identification: Cases were identified via structured queries to the obstetric electronic medical record (EMR – NeSS Technologies, Israel). For the study group, the query identified women admitted during the study period who (1) had undergone CD prior to GW37 within one week of admission and (2) had an admission or discharge rupture of membranes diagnosis. If discrepancy was noted between admission and discharge diagnoses, the medical record was reviewed; if rupture of membranes was not recorded on admission or throughout hospitalization, the case was excluded. Data missing from the EMR were completed from hard copy files.
For control, the query identified women undergoing CD at GW37-40 with no trial of labour. Due to a large quantity of eligible subjects, those without full EMR data (as described below) were excluded, without hard copy review.
Variables
Primary outcomes were (1) SIRS and qSOFA criteria fulfilment among the study population and (2) as compared to control. Secondary outcomes included (a) availability of the components of the above scores and (b) rates of clinical intraamniotic infection and positive cultures (urine, cervix, placenta and blood) in the two groups.
Thus, vital signs (heart rate, blood pressure, temperature, respiratory rate, mental status) as documented by nursing staff, complete blood count (CBC), creatinine, bilirubin and culture results were collected at admission and on POD 0, 1 and 2.
For purposes of this study, IAI was defined as hospital discharge with a relevant diagnostic code (ICD-9 658.41) or broad spectrum antibiotic treatment during labor and delivery. Though recent evidence advocates additonal of azithromycin to the usal prophylactic antibiotics in many or all women undergoing CD [14], our institutional protocols at the time of the study, in accordance with the best available evidence [15], dictated only narrow spectrum antibiotics as CD surgical prophylaxis and Broad spectrum antibiotics usually Amoxicillin/clavulanate and Gentamycin are used for IAI. Thus, broad spectrum antibiotic use in the obstetric patient in the context of our antibiotic stewardship protocols [16] indicated clinical IAI.
Potential sources of bias
During data collection it was discovered that temperature was not recorded on POD0 for 88/453 (19.4%) of the study group and 900/2004 (44.9%) of control. Upon review, these omissions were noted in women undergoing an evening operation with maternity ward arrival close to midnight. Since these cases comprised a considerable percentage of our study population and time of omission was consistent, concerns arose regarding potential documentation bias. Therefore, women with missing data were compared to those without missing data (Appendix Table 1). The proportion of documentation omissions with regards to blood pressure, heart rate and temperature excluding Post operative day (POD) 0 was negligible and random, therefore women lacking data regarding any of these were excluded from the study (Appendix Table 2). An additional issue was a complete lack of respiratory and mental status documentation patients in either group, precluding calculation of qSOFA.
Table 1
Demographic, obstetric and medical characteristics of study group versus control group. PPROM: preterm premature rupture of membranes; CI: confidence interval
Characteristic
|
PPROM
n = 453 (%)
|
Control n = 2004 (%)
|
p
|
Maternal age (mean ± CI)
|
31.5 ± 6.7
|
33.8 ± 5.3
|
0.001
|
>35 year
|
127 (28.0)
|
750 (37.4)
|
0.001
|
Member of minority
|
70 (15.5)
|
220 (11.0)
|
0.001
|
Completed secondary education
|
411 (90.7)
|
1934 (96.5)
|
0.005
|
Gestation number
|
3.2 ± 2.5
|
3.9 ± 2.6
|
0.001
|
Previous caesareans (mean ± CI)
|
0.4 ± 0.8
|
1.1 ± 1.2
|
0.001
|
Any previous caesarean
|
121 (26.7)
|
1077 (59.9)
|
0.001
|
Previous abortion (mean ± CI)
|
0.7 ± 1.3
|
0.7 ± 1.1
|
0.531
|
In vitro fertilization
|
126 (27.8)
|
319 (15.9)
|
0.001
|
Twin pregnancy
|
160 (35.3)
|
200 (10.0)
|
0.001
|
Gestational diabetes
|
46 (10.2)
|
269 (13.4)
|
0.060
|
Hypertension
|
18 (4.0)
|
69 (3.4)
|
0.581
|
Hypothyroidism
|
29 (6.4)
|
117 (5.8)
|
0.647
|
Table 2
Vital signs and white cell counts of study group versus control group. PPROM: preterm premature rupture of membranes; POD: post-operation day
Characteristic
|
Day
|
PPROM
|
n
|
Control
|
n
|
p
|
Temperature
|
Admission
|
36.73 ± 0.4
|
453
|
36.68 ± 0.3
|
2004
|
0.005
|
POD0
|
36.72 ± 0.5
|
365
|
36.46 ± 0.5
|
1104
|
0.001
|
POD1
|
36.82 ± 0.5
|
453
|
36.81 ± 0.4
|
2004
|
0.367
|
POD2
|
36.69 ± 0.4
|
453
|
36.65 ± 0.4
|
2004
|
0.147
|
Pulse
|
Admission
|
92.7 ± 14.4
|
453
|
88.2 ± 11.4
|
2004
|
0.001
|
POD0
|
84.8 ± 12.5
|
453
|
83.2 ± 10.8
|
2004
|
0.06
|
POD1
|
90.6 ± 11.5
|
453
|
88.8 ± 9.2
|
2004
|
0.029
|
POD2
|
88.9 ± 11
|
453
|
87.8 ± 9.6
|
2004
|
0.34
|
Mean arterial pressure
|
Admission
|
90.3 ± 10.9
|
453
|
85.6 ± 9.3
|
2004
|
0.001
|
POD0
|
76.8 ± 10.5
|
453
|
74.3 ± 9.5
|
2004
|
0.001
|
POD1
|
73.6 ± 9.5
|
453
|
70.8 ± 8.2
|
2004
|
0.001
|
POD2
|
78.2 ± 10
|
453
|
76.8 ± 9.1
|
2004
|
0.008
|
Leukocyte count (*103)
|
Admission
|
10.3 ± 9.2
|
452
|
9.2 ± 2.2
|
1997
|
0.001
|
POD0
|
13.4 ± 11.7
|
310
|
11.7 ± 3.3
|
1617
|
0.001
|
POD1
|
12.2 ± 11.4
|
187
|
11.4 ± 3
|
587
|
0.007
|
POD2
|
11.4 ± 9.7
|
56
|
9.7 ± 2.6
|
138
|
0.005
|
Data collection
SZMC has separate EMRs for obstetric and all other patient data. Cases were identified and vital signs collected from the obstetric EMR and other data from the hospital-wide EMR. As noted above, data unavailable in the EMR was obtained from hard copy files.
For all women, initial data included variables at time of admission. For women not undergoing CD at admission, data were collected from the high risk pregnancy unit. Women who remained in the delivery suite more than 24 hours before CD had data collected there. All data collected after CD were from maternity ward notes.
Sample size considerations: The study was designed as a 1:4 case-control study. Based on previous studies, we hypothesized a 10% IAI rate in the study group[17], with an infection rate of at least 1.7% and no more than 5% in the control [12]. Thus, 437 cases in the study group and 1748 in the control were needed to reject (with a power of 0.95) the null hypothesis of an identical rate of IAI in the study and control groups. Upon initial database review, we identified approximately 600 women with a diagnosis of PPROM. We assumed that about 30% would be eliminated on review. Thus 420 would remain in the study group, of whom approximately 42 (10%) would be found to have an IAI. No more than 2000 subjects were needed in the control group, of whom no more than 100 (5%) would be found to have an IAI. The probability of a type I error associated with this test of the null hypothesis was calculated as 0.05.
Quantitative variables
The lowest systolic blood pressure and highest pulse and fever recorded each day were used for analysis. Glasgow Coma Scale was to be described as the total sum rather than its components. Laboratory data, including leukocyte and platelet count, creatinine and bilirubin, were collected and analysed as presented by the hospital laboratory.
Data management and statistical analysis: Data were downloaded from the EMR to a Microsoft Excel (Version 2010) database and then transferred to SPSS (Version 22.0. Armonk, NY: IBM Corp.), which was used for analysis. Data from hard copy files were manually added to the database.
In the first step, descriptive statistics (i.e. numbers, proportion and means) were used to describe the study population as a whole, as well as study and control group characteristics (Table 1).
In the second step, comparisons between women with and without missing data were performed and in the third step, comparisons between study and control groups were performed. Comparison between proportions was performed using the χ2-score (e.g. for demographic and clinical features) or the Fisher’s exact test (e.g. for the rate of positive cultures). To compare continuous variables the Student’s t-test (e.g. for maternal age) or the Mann-Whitney-Wilcoxon test (e.g. for vital signs and obstetric characteristics such as number of gestations and previous CDs) were used. In all tests, two-tailed p-values were taken and a p-value < 0.05 was considered significant.
Finally, we performed sensitivity analyses comparing positive urinary culture rates between groups.